C4 Therapeutics, Inc. · NASDAQ:CCCC
Ra Capital Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc., 11,383,696 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 11,383,696
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 11,383,696 |
| Peter Kolchinsky | 9.90% | 11,383,696 |
| Rajeev Shah | 9.90% | 11,383,696 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 11,383,696 |
Source
Related
- C4 Therapeutics, Inc.
- Ra Capital Management, L.P.
- C4 Therapeutics, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Oct 24, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026